Stock Ratings | HC Wainwright raised its target for Enlivex (ENLV) to $80, with a potential upside of 3586.64%; Piper Sandler initiated coverage of CoreWeave (CRWV) with an "overweight" rating and a target of $151.
Enlivex ENLV | 0.00 | |
Pharming Group NV Sponsored ADR PHAR | 0.00 | |
Ovid Therapeutics Inc. OVID | 0.00 | |
Pyxis Oncology, Inc. PYXS | 0.00 | |
Inovio Pharmaceuticals, Inc. INO | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
HC Wainwright & Co.: Maintaining a "buy" rating on Enlivex ( Enlivex(ENLV.US) ), with a price target raised from $20 to $80.
Canaccord Genuity: Maintaining a "buy" rating on Pharming Group NV Sponsored ADR ( Pharming Group NV Sponsored ADR(PHAR.US) ), with a price target raised from $37 to $38.
Oppenheimer: Maintaining an "outperform" rating for Ovid Therapeutics ( Ovid Therapeutics Inc.(OVID.US) ), while raising the price target from $7 to $9.
Wells Fargo: Initial rating for Pyxis Oncology ( Pyxis Oncology, Inc.(PYXS.US) ) at "overweight", with a price target of $12.
Piper Sandler: Affirming the "overweight" rating for Inovio Pharmaceuticals ( Inovio Pharmaceuticals, Inc.(INO.US) ), with a price target cut from $6 to $4.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| Enlivex(ENLV.US) | to lift | $80.0 | $2.17 | 3586.64% | HC Wainwright & Co. |
| Pharming Group NV Sponsored ADR(PHAR.US) | to lift | $38.0 | $9.82 | 286.97% | Canaccord Genuity |
| Ovid Therapeutics Inc.(OVID.US) | to lift | $9.0 | $2.33 | 286.27% | Oppenheimer |
| Applied Digital(APLD.US) | to lift | $75.0 | $29.49 | 154.32% | B. Riley Securities |
| TeraWulf Inc.(WULF.US) | to lift | $40.0 | $18.83 | 112.43% | B. Riley Securities |
| Pyxis Oncology, Inc.(PYXS.US) | Initial classification | $12.0 | $3.04 | 294.74% | Wells Fargo |
| Inovio Pharmaceuticals, Inc.(INO.US) | cut | $4.0 | $0.6968 | 474.05% | Piper Sandler |
| Westwater Resources Inc(WWR.US) | cut | $1.5 | $0.4324 | 246.9% | HC Wainwright & Co. |
| Alnylam Pharmaceuticals, Inc(ALNY.US) | cut | $450.0 | $220.33 | 104.24% | Barclays |
| Madrigal Pharmaceuticals, Inc.(MDGL.US) | cut | $962.0 | $482.0 | 99.59% | Barclays |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
B. Riley Securities: Maintaining a "buy" rating on Applied Digital ( Applied Digital(APLD.US) ), with a price target raised from $66 to $75.
UBS: Maintaining a "buy" rating on AppLovin ( AppLovin(APP.US) ), while raising its price target from $750 to $798.
BNP Paribas: Upgrades Boeing Boeing Company(BA.US) ) to "Outperform Market", raising its price target from $230 to $300.
Cantor Fitzgerald: Maintaining an "overweight" rating on Datadog ( Datadog(DDOG.US) ), while raising the price target from $226 to $327.
BTIG: Maintaining a "buy" rating on Snowflake Snowflake(SNOW.US) ) stock, while raising the price target from $325 to $340.
First Coverage
Piper Sandler: CoreWeave ( CoreWeave(CRWV.US) ) initial rating at "overweight", with a price target of $151.
Guggenheim: Sherwin-Williams stock ( Sherwin-Williams Company(SHW.US) ) has a preliminary rating of "buy", with a target price of $400.
Piper Sandler: Initial rating for Nebius Group ( NEBIUS(NBIS.US) ) stock at "neutral", with a price target of $224.
reduction
Cantor Fitzgerald: Maintaining an "overweight" rating for Coinbase Global Coinbase(COIN.US) stock, while lowering the price target from $250 to $184.
Cantor Fitzgerald: Maintaining an "overweight" rating on Robinhood Markets ( Robinhood(HOOD.US) ), while lowering the price target from $130 to $115.
Stifel: Maintaining a "buy" rating on Tesla Tesla Motors, Inc.(TSLA.US) ) stock, while lowering the price target from $508 to $491.
HC Wainwright & Co.: Maintaining a "buy" rating on Westwater Resources ( Westwater Resources Inc(WWR.US) ), while lowering the price target from $1.75 to $1.50.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.